<DOC>
	<DOC>NCT02131220</DOC>
	<brief_summary>The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.</brief_summary>
	<brief_title>Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Saruplase</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>STsegment elevation AMI within 12 hours of symptom onset Contraindications to thrombolysis or PCI Patients administered a fibrinolytic agent before PCI Patients enrolled in clinical trials</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>No-Reflow Phenomenon</keyword>
</DOC>